Home
About
FAQ
History (1)
DAB389IL2 (ONTAK) fusion protein therapy of chronic lymphocytic leukaemia.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
DAB389IL2 (ONTAK) fusion protein therapy of chronic lymphocytic leukaemia.
Frankel AE, Fleming DR, Powell BL, Gartenhaus R. DAB389IL2 (ONTAK) fusion protein therapy of chronic lymphocytic leukaemia. Expert Opin Biol Ther. 2003 Feb; 3(1):179-86.
View in:
PubMed
subject areas
Aged
Animals
Diphtheria Toxin
Female
Humans
Interleukin-2
Leukemia, Lymphocytic, Chronic, B-Cell
Male
Middle Aged
Pilot Projects
Recombinant Fusion Proteins
authors with profiles
Bayard L. Powell MD